Searched for
BEDAQUILINE
Plans to restrict open market access to tuberculosis medicinesIndia is tightening access to anti-TB drugs Bedaquiline and Delamanid due to rising drug-resistant tuberculosis cases and potential misuse ...- Pharma cos can supply generic Bedaquiline to other countriesMultinational pharmaceutical company Johnson & Johnson (J&J) has announced that it will not enforce secondary patents for its anti-TB drug ...
- J&J, Lupin cut prices for tuberculosis drug in lower-income countriesJohnson & Johnson and Lupin will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and mi...
- MSF asks Johnson & Johnson to step away from secondary patents for key TB drugMedical charity Medecins Sans Frontieres (MSF) has once again urged Johnson & Johnson (J&J) to not enforce any 'secondary' patents for its ...
- TB drug deal offers short term solution, excludes high burden nations, says health advocacy group“The deal remains just a stop-gap because bedaquiline will only be available to a limited number of countries that will be included in this...
- 'Stop TB' sets ball rolling for Bedaquiline's generic cloneStop TB Partnership has invited tenders for the production of bedaquiline, the first new therapy to be made available for tuberculosis (TB)...
- Johnson & Johnson tuberculosis drug's final patent hearing set for todayThe latest secondary patent application, if granted, allows J&J to extend the monopoly on the drug used for treatment of drug resistant (DR...
- Two TB survivors fight Johnson & Johnson monopoly bidAt present, only 2% of over 1.47 lakh patients suffering from multi drug resistant TB in India are currently getting Bedaquiline.
- Johnson and Johnson asked to cut down price of new TB drugTo ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price...
- Price of J&J’s TB drug to drop by more than halfLife-saving drug bedaquiline by US pharma company Johnson & Johnson (J&J) is now being offered at $400 per patient —over 50% cheaper than t...
- Johnson and Johnson to offer first TB drug in 40 years for $900J&J said India is eligible for the lowest global price and that it is working on a sustainable access strategy.
- Johnson & Johnson , Mylan propose ways to cut TB drugs prices in IndiaJ&J has offered to provide one course of the drug bedaquiline for free if the government buys four courses at $900 (₹58,400) each.
- India's dependency on charitable program for MDR TB drugs not helping, doctors sayIndia's dependency on charity from global drug makers is making it hard for patients to access new antibiotic drugs such as bedaquiline and...
- Drug to treat MDRTB to be made available across the country: GovernmentUnion Health Minister J P Nadda, in a written reply, said that the states are being prepared to monitor the treatment of patients with Beda...
- TB patients will not be denied treatment on basis of domicile: GovernmentIn December 2016, the father of an 18-year-old patient suffering from XDR TB took National Institute of Tuberculosis and Respiratory Diseas...
- Govt agrees to provide new TB drug to a Bihar girlBedaquiline and Delamanid are considered the drug for patients like the Bihar girl. Both drugs can’t be bought in pharmacies and are availa...
- Hospital denies new TB drug to dying patient citing fear of drug resistanceLRS was responding to an affidavit asking whether the govt could provide the bedaquiline directly to the treating doctor instead of the pat...
- Battle for access to tuberculosis medicine reaches HC"Patients need to be constantly monitored, which is why these centres are currently administering the drug only to residents of these six s...
- Government launches new medicine to treat drug resistant TBAhead of World Tuberculosis Day on March 24, government today launched Bedaquiline, a new class of anti-tuberculosis medicine discovered to...
- Government drags feet on effective anti-TB drug BedaquilineGovernment officials say there are several reasons for this: bedaquiline is technically still in a trial phase and its cost in some high-in...
Load More
